Scientists at The Institute of Cancer Research in Sutton have found the LOX inhibitor can slow its growth and spread in mice.
Lobular makes up about 15% of all breast cancers, beginning in the milk producing-glands known as lobules.
The researchers now hope to progress the drug to clinical trials.
